This inventor holds 1 USPTO granted patent. Top assignee: Smt Bio Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jung-Min Im: Inventor in Cancer Research
Introduction
Jung-Min Im is an inventor based in Gwangmyeong-si, South Korea. His patent work concerns a potential immunotherapy approach for extrahepatic bile duct cancer.
Latest Patents
Im is associated with 1 patent: “Composition for Preventing or Treating Extrahepatic Bile Duct Cancer.” The invention describes a pharmaceutical composition containing natural killer (NK) cells and an anti-PD-1 antibody as active ingredients, intended to prevent or treat extrahepatic bile duct cancer.
Career Highlights
Im is associated with Smt Bio Co., Ltd. His listed patent reflects work at the intersection of cellular immunotherapy and cancer treatment.
Collaborations
His listed coworkers include Yong-Yoon Chung and In-Hye Jung.
Conclusion
Jung-Min Im’s patent focuses on combining NK cells with an anti-PD-1 antibody as a proposed approach to preventing or treating extrahepatic bile duct cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile